Ligand validation:6RVP

MB3: 1-methylpyrrolidin-2-one

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6RVP_MB3_A_403	62%	36%	0.088	0.878	1.54	0.9	2	-	0	0	100%	1
5XDT_MB3_A_404	91%	85%	0.073	0.964	0.15	0.52	-	-	0	0	100%	1
6YD6_MB3_A_404	85%	43%	0.071	0.941	1.16	0.95	1	-	0	0	100%	1
6YD5_MB3_A_402	75%	47%	0.09	0.924	1.14	0.84	1	-	0	0	100%	1
4QSS_MB3_A_1207	97%	41%	0.06	0.986	1.24	0.98	1	-	0	0	100%	1
3MB4_MB3_B_1	85%	59%	0.083	0.953	0.86	0.57	-	-	0	0	100%	1
3P1D_MB3_A_1198	76%	64%	0.12	0.961	0.4	0.83	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.